The decreased effectiveness of TNFis and MTX associated with the positivity of anti-Ro/SS-A antibodies has been reported in a population of patients with RA and without sSS; that is, anti-Ro/SS-A antibody positivity might also be a refractory factor of RA [27,30]. This evidence concerns the gene RO60 and rheumatoid arthritis.